By How Much Will Roche’s Revenues And Earnings Grow In The Next 3 Years?
By How Much Will Roche’s Revenues And Earnings Grow In The Next 3 Years? Below we provide a Key-Point schematic that very clearly answers this questions. For our complete analysis and topical articles on Roche, see the link below. For similar Key-Point questions and answers, the the list below.
Roche’s Expected Revenue & Earnings Growth Between 2015 – 2018 ~ 10%
Low Growth Due To Expected Biosimilar Competition And Patent Expirations
Have more questions about Roche? See the links below.
- What Drove 15% Growth in Roche’s Earnings Between 2011-2014 Even Though Other Big Pharma Companies Suffered A Decline?
- Why Is Market Assigning Low Earnings Multiple To Roche Despite Its Biotech Focus?
- Can Roche Grow Its Earnings By 15% In The Next 3 Years?
- With Biosimilars Getting Approval In Europe, Does Roche’s 2016 EPS Face A Meaningful Risk?
- How Can Roche Get 25% Boost In Revenues In 5 Years?
- Can Emerging Biosimilar Competition Cause > 10% Downside To Roche’s Valuation?
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)